These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 20113887)
1. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency. Grunebaum E; Roifman CM Immunol Allergy Clin North Am; 2010 Feb; 30(1):63-73. PubMed ID: 20113887 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency. Grunebaum E; Roifman CM Hematol Oncol Clin North Am; 2011 Feb; 25(1):63-73. PubMed ID: 21236390 [TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related]
5. Matched unrelated bone marrow transplant for severe combined immunodeficiency. Roifman CM; Grunebaum E; Dalal I; Notarangelo L Immunol Res; 2007; 38(1-3):191-200. PubMed ID: 17917025 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428 [TBL] [Abstract][Full Text] [Related]
8. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093 [TBL] [Abstract][Full Text] [Related]
9. HLA-haploidentical donor transplantation in severe combined immunodeficiency. Friedrich W; Hönig M Immunol Allergy Clin North Am; 2010 Feb; 30(1):31-44. PubMed ID: 20113885 [TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471 [TBL] [Abstract][Full Text] [Related]
11. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644 [TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity. Nagler A; Brautbar C; Slavin S; Bishara A Bone Marrow Transplant; 1996 Nov; 18(5):891-7. PubMed ID: 8932842 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation for severe combined immune deficiency. Grunebaum E; Mazzolari E; Porta F; Dallera D; Atkinson A; Reid B; Notarangelo LD; Roifman CM JAMA; 2006 Feb; 295(5):508-18. PubMed ID: 16449616 [TBL] [Abstract][Full Text] [Related]
15. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation. Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071 [TBL] [Abstract][Full Text] [Related]
16. Donor and host influences in bone marrow transplantation for immunodeficiency disease and leukemia. Kersey J; Filipovich A; McGlave P; Woods W; Weisdorf D; Neglia J; Dusenbery K; Blazar B; Nesbit M; Ramsay N Semin Hematol; 1993 Oct; 30(4 Suppl 4):105-8; discussion 109. PubMed ID: 8303303 [TBL] [Abstract][Full Text] [Related]
17. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency. Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052 [TBL] [Abstract][Full Text] [Related]